Concentration (μg/ml) | % Viability |
---|
Aqueous extract | Ethanolic extract | Pet. ether extract | Paclitaxel |
---|
0 | 100 ± 6.198 | 100 ± 6.198 | 100 ± 6.198 | 100 ± 2.44 |
6.25 | - | - | - | 86.25 ± 0.441** |
12.5 | - | - | - | 45.36 ± 0.582** |
25 | 89.50 ± 0.883 | 80.57 ± 1.972* | 46.68 ± 5.838** | 29.51 ± 1.54** |
50 | 71.01 ± 2.141** | 59.04 ± 3.507** | 36.89 ± 3.525** | 16.46 ± 2.313** |
100 | 61.44 ± 1.129** | 36.38 ± 1.396** | 18.73 ± 2.505** | - |
200 | 52.43 ± 0.745** | 11.85 ± 2.371** | 10.84 ± 2.741** | - |
IC 50 value | 211.26 | 87.24 | 22.5a
| 13.91a
|
- Results were expressed as Mean ± SEM (n = 3) and analysed using one-way ANOVA followed by Tukey’s post hoc test of significance [where different alphabets a, b denote significant difference (p <0.05)]. Statistical comparison between the mean % viability of each extract and its negative control was performed using one-way ANOVA followed by Dunnett’s post hoc test of significance wherein *p <0.05 and **p <0.01 were considered to be statistically significant and very statistically significant compared to negative control. A.carnosus extracts were not tested at concentrations of 200, 100, 50, 25 μg/ml (they were not tested at concentrations of 6.25 and 12.5 μg/ml). Paclitaxel was tested at concentrations of 6.25, 12.5, 25 and 50 μg/ml.